As I write this preface in April 2020, the world is in the grip of a hitherto unimagined coronavirus pandemic which has turned all our lives upside down and sadly ended the lives of many thousands. My wife and I have been in lockdown, along with many millions of others, for over 4 weeks, and this is set to continue for some while, perhaps until the pandemic abates. By some miracle the authors of this volume have all managed to complete their individual chapters, so I will start by thanking them and their families for their tremendous efforts at this extraordinary time.

That most of us will emerge intact is in no small measure due to the bravery, hard work, and dedication of countless medical and clinical staff. They and the politicians of many countries have been guided by the insights of the scientific community, who have been rapidly learning what a hard target COVID-19 has proved to be. Once the world enters, what will undoubtedly be a long period of economic and social recovery, then will be the time for nations to reassess where their scientific priorities are best directed. It is safe to assume that much future effort will be focused on innovative therapies for communicable diseases, and it is to end that the concepts presented in this book are directed. Hitherto, quadruplex targeting by small molecules has in large part been applied to human cancers, and we are beginning to see the fruits of this with compounds coming into clinical trial. This effort will surely continue, but as shown in several chapters in this book, application of the concept to viral and other diseases can work, at least in the laboratory. Medicinal chemistry is crucial in ensuring that a compound that starts off with potency against its targets and in cells, can realistically be developed into a therapeutic agent for human use.

The quadruplex therapeutic concept, detailed by Laurence Hurley in his Foreword, is just 23 years old. In 2006, Shankar Balasubramanian and I edited a book on quadruplexes, comprehensively covering both fundamental and more applied aspects of the field. This level of coverage is no longer possible, with currently over 6000 primary publications in the literature. The field has also moved on, from being initially mostly chemistry-based, to one in which the role of quadruplexes in biological processes are the focus of much investigation. This book aims to illustrate both to those new to the topic and experienced practitioners, how chemistry and biology is coming together to create effective ways of targeting quadruplexes. It highlights a number of the most active areas of current study, and I have been fortunate in being able to persuade the many of the leading authorities in these fields to contribute.

I am grateful to my past and current collaborators for their contributions to my thinking on the subject. The authors of the chapters in this book have magnificently responded to the current challenges and have incredibly delivered their chapters on time. I must especially mention and thank those Italian authors, who have continued to write despite the terrible effects of the coronavirus in Italy. I was fortunate to have Laurence Hurley as collaborator 23 years ago when we worked together to demonstrate the quadruplex proof of concept. Since then his insights have been fundamental to the progression of the quadruplex field and so I am delighted that he agreed to write the Foreword for this book. Finally I thank my wife Andrea for all her support, encouragement, and wisdom, not least during these past few weeks.
